Table 2.
Parameters | Suspected EOS (n=149)Group 1 | Proven EOS (n=67)Group 2 | Control Group (n=92)Group 3 | P value |
---|---|---|---|---|
Platelet count, 103/L(mean ± SD) | 245.7 ±66.1 | 237.1 ±54.3 | 283.4 ±77.6 | Group 1–3: >0.05 Group 2–3: >0.05 |
Lymphocyte 103/L(mean ± SD) | 7.4 ±2.1 | 6.5 ±1.3 | 13.1 ±2.9 |
Group 1–3; <0.001 Group 2–3; <0.001 |
PLR(mean ± SD) | 0.073 ±0.035 | 0.089 ±0.044 | 0.055 ±0.012 |
Group 1–3; <0.001 Group 2–3; <0.001 |
CRP mg/L(mean ± SD) | 27.5 ±6.3 | 56.9 ±21.7 | 4.6 ±1.1 |
Group 1–3; <0.001 Group 2–3; <0.001 |
PCT ng/mL(mean ± SD) | 2.2 ±0.09 | 3.4 ±1.2 | 0.03 ±0.01 |
Group 1–3; <0.001 Group 2–3; <0.001 |
I/T ratio(mean ± SD) | 0.25 ±0.1 | 0.33 ±0.08 | 0.1 ±0.05 |
Group 1–3; <0.001 Group 2–3; <0.001 |
WBC 109/L(mean ± SD) | 27.8 ±6.1 | 33.4 ±7.5 | 23.1 ±5.2 |
Group 1–3; <0.001 Group 2–3; <0.001 |
EOS, early-onset sepsis; SD: standard deviation; PLR, platelet to lymphocyte ratio; CRP, C-reactive protein; PCT, Procalcitonin; I/T, immature to total neutrophil; WBC, white blood cell.